APPLICATION
ANDA090108
TYPE
ANDA
ORIGINAL APPROVAL
2011-09-30
LATEST ACTION
2026-07-13
ROUTE
INTRAMUSCULAR, INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
CLINDAMYCIN PHOSPHATEPrescription
CLINDAMYCIN PHOSPHATE EQ 150MG BASE/ML · INJECTABLE · INJECTION
Approval history
2026-07-13Labeling · Supplement 25 · standardAP
2026-07-13Labeling · Supplement 26 · standardAP
2021-02-11Labeling · Supplement 15 · standardAP
2021-02-11Labeling · Supplement 13 · standardAP
2021-02-11Labeling · Supplement 11 · standardAP
2018-04-16Labeling · Supplement 6 · standardAP
2018-04-16Labeling · Supplement 10 · standardAP
2018-04-16Labeling · Supplement 9 · standardAP
2018-04-16Labeling · Supplement 5 · standardAP
2011-09-30OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.